Document ID: chunk:federal_register_of_legislation:F2021L00028:reg:8:p3
Version: federal_register_of_legislation:F2021L00028
Segment Type: reg
Provision Reference: reg 8 (pt 3/3)
Character Range: 8275–9935

disorders at the time of the clinical worsening of hyperacusis;
Note: specified list of inner ear disorders is defined in the Schedule 1 - Dictionary.
(29)      having Meniere's disease at the time of the clinical worsening of hyperacusis;
(30)      having paralysis of the facial nerve on the affected side at the time of the clinical worsening of hyperacusis;
Note 1: The facial nerve is also known as the seventh cranial nerve.
Note 2: Facial nerve paralysis is also known as Bell's palsy.
            Note 3: Conditions that can cause paralysis of the facial nerve include autoimmune disease, multiple sclerosis and viral infection.
(31)      having a viral or bacterial infection from the specified list of viral or bacterial infections within the 30 days before the clinical worsening of hyperacusis;
Note: specified list of viral or bacterial infections is defined in the Schedule 1 - Dictionary.
(32)      having dysfunction of the stapedius muscle or the tensor tympani muscle on the affected side at the time of the clinical worsening of hyperacusis;
(33)      having a middle cerebral artery aneurysm at the time of the clinical worsening of hyperacusis;
(34)      having a cerebrovascular accident within the 30 days before the clinical worsening of hyperacusis;
(35)      having multiple sclerosis at the time of the clinical worsening of hyperacusis;
(36)      undergoing withdrawal following long-term benzodiazepine use within the seven days before the clinical worsening of hyperacusis;
Note: long-term benzodiazepine use is defined in the Schedule 1 - Dictionary.
(37)      inability to obtain appropriate clinical management for hyperacusis.